Quantitative Dynamic (18)F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors

SIMPLE SUMMARY: The reliable and early during-the-course-of-treatment assessment of tumor response to the novel immunotherapeutic agents is a matter of debate, posing relevant challenges to conventional imaging modalities. In this prospective study, including 25 metastatic melanoma patients, we expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachpekidis, Christos, Hassel, Jessica C., Kopp-Schneider, Annette, Haberkorn, Uwe, Dimitrakopoulou-Strauss, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957728/
https://www.ncbi.nlm.nih.gov/pubmed/33804417
http://dx.doi.org/10.3390/cancers13051019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957728/
https://www.ncbi.nlm.nih.gov/pubmed/33804417
http://dx.doi.org/10.3390/cancers13051019

Ejemplares similares